Shire to Launch Six Products in 2010, Including Genzyme Competitor

Drug Industry Daily
A A
Shire Pharmaceuticals expects to launch six products in various markets in 2010, including a U.S. and EU introduction of its Gaucher’s disease treatment Vpriv, which will compete with Genzyme’s Cerezyme.

To View This Article:

Login

Subscribe To Drug Industry Daily